GLENMEDE TRUST CO NA - KITE PHARMA INC ownership

KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of KITE PHARMA INC
ValueSharesWeighting
Q3 2016$1,000
-66.7%
21
-61.8%
0.00%
Q4 2015$3,0000.0%550.0%0.00%
Q3 2015$3,0000.0%550.0%0.00%
Q2 2015$3,0000.0%55
-11.3%
0.00%
Q1 2015$3,0000.0%62
+12.7%
0.00%
Q4 2014$3,000550.00%
Other shareholders
KITE PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 2,410,034$433,348,00077.71%
COWEN INC. 4,200,600$755,310,00026.72%
Tyrus Capital S.A.M. 1,314,812$236,416,00018.49%
OMNI PARTNERS LLP 661,711$118,982,00015.19%
FNY Partners Fund LP 379,510$68,239,00011.61%
EQUITEC PROPRIETARY MARKETS, LLC 240,100$43,172,00010.15%
EQUITEC PROPRIETARY MARKETS, LLC 227,500$40,907,0009.62%
GARDNER LEWIS ASSET MANAGEMENT L P 773,817$139,140,0008.89%
Quad Capital Management Advisors LLC 192,537$34,620,0007.10%
Avoro Capital Advisors LLC 496,983$89,363,0006.93%
View complete list of KITE PHARMA INC shareholders